Latest Blog: 18th January 2022
Regenerative medicine – A phenomenal year for new therapies and distributed manufacturing
Today marks a new milestone for cell and gene therapy pioneer Ori Biotech , as the company unveils an oversubscribed $100 million Series B funding round led by Novalis LifeSciences, increasing the total capital raised since inception two years ago to $140m. The raise will fuel market launch of the Ori system, a full stack, [...]